QLTI GMO International Quality ETF
ETF on NYSE (US) · Actively managed · Listing
Most notable sale · Taiwan Semiconductor Manufacturing Company Ltd.
Taiwan Semiconductor Manufacturing Company Ltd. cut by 7%
Shares went from 40,629 to 37,807 ($17.0M → $15.7M). Now 5.3% of the portfolio. Estimated trade $1.17M.
Most notable buy · Sika AG
New position in Sika AG
11,407 units worth $2.71M. Now 0.9% of the portfolio.
Largest holding: Taiwan Semiconductor Manufacturing Company Ltd., cut 7%, 37,807 shares ($15.7M).
| Current positions Top 10 | % of book |
|---|---|
| Taiwan Semiconductor Manufacturing Company Ltd. TSM $15.7M · −7% sh | 5.3% |
| INDUSTRIA DE DISEÑO TEXTIL, S.A. ITX $15.7M · −<1% sh | 5.3% |
| SAP SE SAP $14.0M · −<1% sh | 4.7% |
| Unilever PLC UL $12.3M · −<1% sh | 4.1% |
| Novartis AG NVS $11.5M · −<1% sh | 3.9% |
| AMADEUS IT GROUP SOCIEDAD ANONIMA AMS $11.4M · −<1% sh | 3.8% |
| Kerry Group plc KYGA $11.4M · −<1% sh | 3.8% |
| ASML Holding N.V. ASML $11.3M · −<1% sh | 3.8% |
| Safran SA $11.3M · −<1% units | 3.8% |
| L'Oreal SA $11.2M · −<1% units | 3.8% |
Slices are % of holdings value. Changes ("sh" shares, "units" other holdings) are in the quantity held against May 31, 2026.
| Sectors | % of holdings value |
|---|---|
| Technology | 21.0% |
| Consumer Defensive | 16.1% |
| Industrials | 9.9% |
| Consumer Cyclical | 8.4% |
| Healthcare | 6.1% |
| Unclassified | 38.5% |
| Industries | % of holdings value |
|---|---|
| Software - Application | 11.1% |
| Household & Personal Products | 7.8% |
| Semiconductors | 5.3% |
| Apparel Retail | 5.3% |
| Beverages - Non-Alcoholic | 4.5% |
| Drug Manufacturers - General | 3.9% |
| Packaged Foods | 3.8% |
| Other (9) | 19.8% |
| Unclassified | 38.5% |
| Initiations 1 | Value |
|---|---|
| Sika AG 0.9% of portfolio | $2.71M |
| Increases 2 | Change |
|---|---|
| Brambles Ltd $6.42M → $8.76M | +16% |
| Air Liquide SA $10.5M → $10.9M | +9% |
| Reductions 31 | Change |
|---|---|
| Taiwan Semiconductor Manufacturing Company Ltd. TSM $17.0M → $15.7M | −7% |
| Tokyo Electron Ltd $5.10M → $4.52M | −17% |
| INDUSTRIA DE DISEÑO TEXTIL, S.A. ITX $14.5M → $15.7M | −<1% |
| SAP SE SAP $11.6M → $14.0M | −<1% |
| Unilever PLC UL $10.7M → $12.3M | −<1% |
| Novartis AG NVS $11.4M → $11.5M | −<1% |
| AMADEUS IT GROUP SOCIEDAD ANONIMA AMS $10.8M → $11.4M | −<1% |
| Kerry Group plc KYGA $10.0M → $11.4M | −<1% |
| Safran SA $10.4M → $11.3M | −<1% |
| ASML Holding N.V. ASML $10.8M → $11.3M | −<1% |
| L'Oreal SA $11.3M → $11.2M | −<1% |
| Roche Holding AG $10.8M → $11.0M | −<1% |
| Terminations 0 | Change |
|---|---|
| None this period. | |
The other 19 reductions
Haleon PLC (−<1%), Compass Group PLC (−<1%), Knorr-Bremse Aktiengesellschaft (−<1%), ASSA Abloy (−<1%), Diageo plc (−<1%), LVMH Moet Hennessy Louis Vuitton SE (−<1%), Dassault Systèmes SE (−<1%), Ryanair Holdings plc (−<1%), Schneider Electric SE (−<1%), Shin-Etsu Chemical Co Ltd (−<1%), KONE Oyj (−<1%), Hoya Corp (−<1%), Fomento Economico Mexicano S.A.B. de C.V. (−<1%), Experian PLC (−<1%), Davide Campari-Milano N.V. (−<1%), Sartorius Stedim Biotech S.A. (−<1%), Biomerieux (−<1%), EssilorLuxottica SA (−<1%), Capgemini SE (−<1%)
Source: the fund's quarterly portfolio reports to the SEC, the portfolio of Aug 31, 2026 (Form N-PORT) vs the portfolio of May 31, 2026 (Form N-PORT). Percent changes are changes in the quantity held (shares, or units for holdings that are not a listed equity); dollar values are as reported at each period end. Each column is ranked by the estimated dollar size of the trade: a new or closed position at its value, otherwise the change in shares at the position's own period-end price. Where shares and price per share moved by inverse whole multiples (a split), the earlier share count is restated. Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.
Objective
From the summary prospectus filed Jun 30, 2026.
Total return.
Principal investment strategies
The Fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing primarily in non-U.S. equities that the Fund's adviser, Grantham, Mayo, Van Otterloo & Co. LLC ("GMO" or the "Adviser"), believes to be of high quality. GMO believes a high quality company generally to be a company that has an established business that will deliver a high level of return on past investments and that will use cash flows to make investments with the potential for a high return on capital or to return cash to shareholders through dividends or share buybacks. Equity securities primarily include common and preferred stocks and, to a lesser extent, other stock-related securities, such as convertible securities, depositary receipts, equity real estate investment trusts ("REITs"), income trusts, and securities of other investment companies that invest primarily in equity securities. In selecting securities for purchase and sale by the Fund, GMO uses a combination of investment methods, typically considering both (1) systematic factors, based on profitability, profit stability, leverage, and other publicly available financial information, and (2) judgmental factors, based on GMO's assessment of future profitability, capital allocation, growth opportunities, and sustainability against competitive forces. The weight that each systematic and judgmental factor is given for a particular security varies over time and GMO INTERNATIONAL QUALITY ETF depends on GMO's assessment of the factor's materiality and relevance to that security. GMO also may rely on valuation methodologies, such as discounted cash flow analysis and multiples of price to earnings, revenues, book values or other fundamental metrics with the objective of buying higher quality stocks at a discount to what GMO believes to be their fundamental fair (or intrinsic) value. The Fund is not subject to any limit on the frequency with which portfolio securities may be purchased or sold, and GMO makes investment decisions for the Fund without regard to portfolio turnover rates. At times, the Fund may have substantial exposure to a single asset class, industry, sector, country, region, issuer, or currency or companies with similar market capitalizations. The Fund may invest in securities of companies of any market capitalization. The Fund may invest in both developed and emerging market securities. The factors GMO considers and investment methods GMO uses can change over time. GMO does not manage the Fund to, or control the Fund's risk relative to, any securities index or securities benchmark. In addition, the Fund may lend its portfolio securities. Under normal circumstances, the Fund invests directly and indirectly at least 80% of its assets in equities of quality companies (see "Name Policies"). The term "quality company" means a company that (i) is included in an independently maintained index of quality companies ("Quality Index"); (ii) has financial and business characteristics that GMO determines to be similar to those of companies included in a Quality Index; or (iii) rates in the top 50% of GMO's quality rankings for companies within the Fund's investment universe.
Management and Contact
- Adviser
- Grantham, Mayo, Van Otterloo & Co. LLC
- Portfolio managers
-
LLC Investment Team and Senior Members of GMO primarily responsible for portfolio management of the Fund: Investment Team Senior Member (Length of Service with Fund) Title Focused Equity Thomas Hancock (since the Fund's inception in 2024) Head, Focused Equity Team, GMO.
Focused Equity Ty Cobb (since the Fund's inception in 2024) Portfolio Manager, Focused Equity Team, GMO.
Focused Equity Anthony Hene (since the Fund's inception in 2024) Portfolio Manager, Focused Equity Team, GMO.
- [email protected]
Track Record as of Dec 31, 2025
Average annual total returns from the summary prospectus. Returns in percent; periods over a year are annualized.
| 1 Year | |
|---|---|
| Return Before Taxes | 16.90% |
| Return After Taxes on Distributions | 16.82% |
| Return After Taxes on Distributions and Sale of Fund Shares | 10.17% |
| MSCI World ex USA Index1 (returns reflect no deduction for fees or expenses, but are net of withholding tax on dividend reinvest | 31.85% |
Holdings as of Aug 31, 2026
The full portfolio as of the quarter end Aug 31, 2026, from the fund's report to the SEC (Form N-PORT, filed Oct 29, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of May 31, 2026.
36 lines, 20 linked, weights sum to 99.98% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| Taiwan Semiconductor Manufacturing Co Ltd | US8740391003 | Equity | 37,807 | −2,822 | 5.29% | $ 15.702M |
| Industria de Diseno Textil SA | ES0148396007 | Equity | 232,390 | −1,086 | 5.27% | $ 15.656M |
| SAP SE | US8030542042 | Equity | 63,241 | −296 | 4.70% | $ 13.969M |
| Unilever PLC | US9047678035 | Equity | 189,439 | −885 | 4.14% | $ 12.285M |
| Novartis AG | US66987V1098 | Equity | 75,768 | −354 | 3.88% | $ 11.521M |
| Amadeus IT Group SA | ES0109067019 | Equity | 168,888 | −789 | 3.84% | $ 11.421M |
| Kerry Group PLC | IE0004906560 | Equity | 116,550 | −545 | 3.83% | $ 11.372M |
| ASML Holding NV | USN070592100 | Equity | 6,690 | −31 | 3.82% | $ 11.346M |
|
Safran SA
|
US7865841024 | Equity | 115,951 | −542 | 3.80% | $ 11.277M |
|
L'Oreal SA
|
US5021172037 | Equity | 125,826 | −588 | 3.78% | $ 11.22M |
|
Roche Holding AG
|
US7711951043 | Equity | 205,407 | −960 | 3.71% | $ 11.03M |
|
Air Liquide SA
|
US0091262024 | Equity | 277,943 | +24,086 | 3.68% | $ 10.923M |
| Haleon PLC | US4055521003 | Equity | 1,084,627 | −5,068 | 3.66% | $ 10.879M |
|
Compass Group PLC
|
US20449X4016 | Equity | 312,218 | −1,459 | 3.20% | $ 9.504M |
| Knorr-Bremse AG | DE000KBX1006 | Equity | 76,066 | −355 | 3.14% | $ 9.33M |
|
Brambles Ltd
|
AU000000BXB1 | Equity | 624,252 | +84,819 | 2.95% | $ 8.763M |
| Assa Abloy AB | SE0007100581 | Equity | 231,651 | −1,082 | 2.91% | $ 8.639M |
| Diageo PLC | US25243Q2057 | Equity | 85,150 | −398 | 2.63% | $ 7.821M |
| Dassault Systemes SE | FR0014003TT8 | Equity | 290,685 | −1,358 | 2.60% | $ 7.712M |
|
LVMH Moet Hennessy Louis Vuitton SE
|
US5024413065 | Equity | 73,516 | −344 | 2.60% | $ 7.71M |
| Ryanair Holdings PLC | US7835132033 | Equity | 134,261 | −627 | 2.50% | $ 7.434M |
|
Schneider Electric SE
|
US80687P1066 | Equity | 103,488 | −484 | 2.38% | $ 7.077M |
|
Shin-Etsu Chemical Co Ltd
|
US8245511055 | Equity | 374,106 | −1,748 | 2.36% | $ 7.003M |
| Kone Oyj | FI0009013403 | Equity | 111,568 | −521 | 2.30% | $ 6.84M |
|
Hoya Corp
|
JP3837800006 | Equity | 42,800 | −200 | 2.22% | $ 6.591M |
| Fomento Economico Mexicano SAB de CV | US3444191064 | Equity | 52,852 | −247 | 2.14% | $ 6.364M |
|
Experian PLC
|
US30215C1018 | Equity | 141,249 | −660 | 1.95% | $ 5.807M |
| Davide Campari-Milano NV | NL0015435975 | Equity | 823,019 | −3,846 | 1.87% | $ 5.564M |
|
Constellation Software Inc/Canada
|
CA21037X1006 | Equity | 2,367 | 0 | 1.80% | $ 5.36M |
|
Tokyo Electron Ltd
|
JP3571400005 | Equity | 12,800 | −2,700 | 1.52% | $ 4.522M |
| Sartorius Stedim Biotech | FR0013154002 | Equity | 16,903 | −79 | 1.30% | $ 3.848M |
| BioMerieux | FR0013280286 | Equity | 31,667 | −148 | 0.93% | $ 2.761M |
|
Sika AG
|
CH0418792922 | Equity | 11,407 | new +11,407 | 0.91% | $ 2.71M |
|
EssilorLuxottica SA
|
US2972842007 | Equity | 27,510 | −129 | 0.86% | $ 2.554M |
|
State Street Global Advisors
|
US8574928706 | Money market | 2,377,995.93 | −242,976.61 | 0.80% | $ 2.378M |
| Capgemini SE | FR0000125338 | Equity | 17,209 | −80 | 0.72% | $ 2.144M |
Trades May 31, 2026 to Aug 31, 2026
Changes in shares between the fund's two newest published portfolios, cash left out. Value is the change at the line's own price in the newer portfolio.
| Holding | Ticker | Action | Before | After | Change | Value |
|---|---|---|---|---|---|---|
|
Sika AG
|
New | — | 11,407 | +11,407 | $ 2.71M | |
|
Brambles Ltd
|
Bought | 539,433 | 624,252 | +84,819 | $ 1.191M | |
| Taiwan Semiconductor Manufacturing Co Ltd | Sold | 40,629 | 37,807 | −2,822 | $ -1.172M | |
|
Tokyo Electron Ltd
|
Sold | 15,500 | 12,800 | −2,700 | $ -953.915K | |
|
Air Liquide SA
|
Bought | 253,857 | 277,943 | +24,086 | $ 946.58K | |
| Industria de Diseno Textil SA | Sold | 233,476 | 232,390 | −1,086 | $ -73.164K | |
| SAP SE | Sold | 63,537 | 63,241 | −296 | $ -65.383K | |
| Unilever PLC | Sold | 190,324 | 189,439 | −885 | $ -57.392K | |
| Novartis AG | Sold | 76,122 | 75,768 | −354 | $ -53.829K | |
| Amadeus IT Group SA | Sold | 169,677 | 168,888 | −789 | $ -53.356K | |
| Kerry Group PLC | Sold | 117,095 | 116,550 | −545 | $ -53.176K | |
|
Safran SA
|
Sold | 116,493 | 115,951 | −542 | $ -52.715K | |
| ASML Holding NV | Sold | 6,721 | 6,690 | −31 | $ -52.576K | |
|
L'Oreal SA
|
Sold | 126,414 | 125,826 | −588 | $ -52.432K | |
|
Roche Holding AG
|
Sold | 206,367 | 205,407 | −960 | $ -51.552K | |
| Haleon PLC | Sold | 1,089,695 | 1,084,627 | −5,068 | $ -50.832K | |
|
Compass Group PLC
|
Sold | 313,677 | 312,218 | −1,459 | $ -44.412K | |
| Knorr-Bremse AG | Sold | 76,421 | 76,066 | −355 | $ -43.544K | |
| Assa Abloy AB | Sold | 232,733 | 231,651 | −1,082 | $ -40.353K | |
| Diageo PLC | Sold | 85,548 | 85,150 | −398 | $ -36.556K | |
|
LVMH Moet Hennessy Louis Vuitton SE
|
Sold | 73,860 | 73,516 | −344 | $ -36.079K | |
| Dassault Systemes SE | Sold | 292,043 | 290,685 | −1,358 | $ -36.027K | |
| Ryanair Holdings PLC | Sold | 134,888 | 134,261 | −627 | $ -34.717K | |
|
Schneider Electric SE
|
Sold | 103,972 | 103,488 | −484 | $ -33.096K | |
|
Shin-Etsu Chemical Co Ltd
|
Sold | 375,854 | 374,106 | −1,748 | $ -32.723K | |
| Kone Oyj | Sold | 112,089 | 111,568 | −521 | $ -31.941K | |
|
Hoya Corp
|
Sold | 43,000 | 42,800 | −200 | $ -30.798K | |
| Fomento Economico Mexicano SAB de CV | Sold | 53,099 | 52,852 | −247 | $ -29.741K | |
|
Experian PLC
|
Sold | 141,909 | 141,249 | −660 | $ -27.133K | |
| Davide Campari-Milano NV | Sold | 826,865 | 823,019 | −3,846 | $ -26K | |
| Sartorius Stedim Biotech | Sold | 16,982 | 16,903 | −79 | $ -17.985K | |
| BioMerieux | Sold | 31,815 | 31,667 | −148 | $ -12.902K | |
|
EssilorLuxottica SA
|
Sold | 27,639 | 27,510 | −129 | $ -11.976K | |
| Capgemini SE | Sold | 17,289 | 17,209 | −80 | $ -9,966.09 |
Podcast Mentions
Sign up to see podcast mentions and sentiment
Sign Up